Related Experiment Video

Updated: Mar 14, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq
09:52

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing ChIP-seq

Published on: April 19, 2013

24.9K

Genetic association study of ABCB1 gene polymorphisms with hypertension in Han Chinese population

X-W Zhang1, J-L Yang, W Liang

  • 1Section of Hypertension, Hospital of Cardiology, Lanzhou University, Second Hospital, Lanzhou, Gansu, China. yujing2304@126.com.

European Review for Medical and Pharmacological Sciences
|September 22, 2016
PubMed

Insights

Genetic variations in the ABCB1 gene are linked to blood pressure and hypertension in Han Chinese individuals, particularly in females. Further research is needed to confirm these findings.

Area of Science:

  • Genetics
  • Cardiovascular Disease Research
  • Population Genetics

Background:

  • Hypertension is a major risk factor for cardiovascular diseases and stroke.
  • Understanding the genetic basis of blood pressure regulation is crucial for developing targeted therapies.
  • The ABCB1 gene plays a role in various physiological processes, but its specific association with hypertension requires further investigation.

Purpose of the Study:

  • To investigate the association between ABCB1 gene polymorphisms and hypertension-related traits.
  • To identify specific single nucleotide polymorphisms (SNPs) in ABCB1 linked to blood pressure variations.
  • To explore potential sex-specific effects of ABCB1 polymorphisms on hypertension in the Han Chinese population.

Main Methods:

  • Genotyping of 13 single nucleotide polymorphisms (SNPs) within the ABCB1 gene in 1154 Han Chinese subjects.
  • Statistical analysis to determine the association between identified SNPs and systolic blood pressure (SBP), diastolic blood pressure (DBP), and hypertension.
  • Stratified analysis to assess potential differences in SNP associations between males and females.

Main Results:

  • Three ABCB1 SNPs (rs17327624, rs3789243, rs4148734) showed significant associations with SBP.
  • Rs17327624 and rs3789243 were significantly associated with DBP.
  • Rs17327624 was significantly associated with hypertension, with a notable effect observed in female subjects for all three identified SNPs.

Conclusions:

  • ABCB1 gene polymorphisms may contribute to blood pressure variation in the Han Chinese population.
  • The identified ABCB1 SNPs show a potential sex-specific effect, with stronger associations observed in females.
  • Further validation in diverse populations is recommended to confirm these findings and elucidate the molecular mechanisms involved.
Abstract

More Related Videos

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene07:00

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

10.5K
Application of DNA Fingerprinting using the D1S80 Locus in Lab Classes08:35

Application of DNA Fingerprinting using the D1S80 Locus in Lab Classes

Published on: July 17, 2021

23.4K

Related Concept Videos

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
90
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.4K
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
93
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
72
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
63
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
73